<DOC>
	<DOCNO>NCT00267176</DOCNO>
	<brief_summary>This study investigate effect ambulatory blood pressure lumiracoxib 100 mg daily versus ibuprofen 600 mg three time day osteoarthritis patient control hypertension .</brief_summary>
	<brief_title>Safety Efficacy Lumiracoxib Patients With Osteoarthritis With Controlled Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Ibuprofen</mesh_term>
	<mesh_term>Lumiracoxib</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<criteria>Osteoarthritis hand , hip , knee spine High blood pressure ( &lt; 140/ 90 mmHg ) control antihypertensive medication ( ) . Exclusion criterion â€¢ Evidence history cardiac cerebral thrombotic/ ischemic disease and/ event Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Osteoarthritis ,</keyword>
	<keyword>hypertension ,</keyword>
	<keyword>lumiracoxib ,</keyword>
	<keyword>ibuprofen ,</keyword>
	<keyword>24-hour blood pressure profile</keyword>
</DOC>